Analytical Data
-
Gene name
CD34
- Application
-
Alternative Names
CD34；Hematopoietic progenitor cell antigen CD34
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P28906
-
Expression Region
33-290aa
-
AA Sequence
LDNNGTATPE LPTQGTFSNV STNVSYQETT TPSTLGSTSL HPVSQHGNEA TTNITETTVK FTSTSVITSV YGNTNSSVQS QTSVISTVFT TPANVSTPET TLKPSLSPGN VSDLSTTSTS LATSPTKPYT SSSPILSDIK AEIKCSGIRE VKLTQGICLE QNKTSSCAEF KKDRGEGLAR VLCGEEQADA DAGAQVCSLL LAQSEVRPQC LLLVLANRTE ISSKLQLMKK HQSDLKKLGI LDFTEQDVAS HQSYSQKT
-
Molecular Weight
27 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CD34 is a glycoprotein expressed on the surface of hematopoietic stem and progenitor cells, playing a vital role in cell adhesion, migration, and differentiation. It serves as a widely recognized marker for identifying and isolating these stem cells in research and clinical applications, particularly in hematology and oncology. The recombinant production of CD34 protein has gained significant interest due to its potential therapeutic implications and applications in regenerative medicine. Understanding the structure and function of CD34 at the molecular level is crucial for developing targeted therapies for various blood disorders and improving stem cell transplantation techniques. Researchers have been exploring different expression systems and purification methods to optimize the yield and activity of recombinant CD34, aiming to study its interactions with specific ligands and signaling pathways. This knowledge can enhance our understanding of hematopoietic cell biology and facilitate advancements in tissue engineering and cell-based therapies. Consequently, the investigation of CD34 recombinant protein is a key focus in the fields of stem cell research and regenerative medicine, promising new avenues for treating a range of conditions related to the hematopoietic system.
